Suppr超能文献

胸腔内吻合口漏食管切除术后使用引流管治疗。

Treatment of intrathoracic anastomotic leak after esophagectomy with the sump drainage tube.

机构信息

Department of Thoracic Surgery, Hebei General Hospital, 348, West He-Ping Road, Shijiazhuang, 050051, Hebei Province, People's Republic of China.

出版信息

J Cardiothorac Surg. 2021 Mar 23;16(1):46. doi: 10.1186/s13019-021-01429-7.

Abstract

BACKGROUND

Intrathoracic esophagogastric anastomotic leak is one of the deadliest complications after esophagectomy. In recent years, we have implemented new method for the treatment of intrathoracic esophagogastric anastomotic leak with the nasogastric placement of sump drainage tube through fistula into abscess cavity. The aim of this study is to compare the efficacy of the new method and conventional therapies for intrathoracic anastomotic leak after esophagectomy.

METHOD

Esophagectomy and esophagogastric anastomotic procedures were performed in 875 patients at our institution from January 2008 to December 2019. Of these patients, 43(4.9%) patients developed intrathoracic anastomotic leaks postoperatively were enrolled into our study and their clinical data were retrospectively assessed. 20 (47%) patients from January 2008 to December 2012 received conventional treatments (group 1) known as the traditional "three-tube method", and 23 (53%) patients from January 2013 to December 2019 received new treatments (group 2), consisted of conventional therapies and the nasogastric placement of sump drainage tube through fistula into abscess cavity.

RESULTS

The presence of intrathoracic anastomotic leak was proven by contrast esophagography in 43 patients (4.9%). Among them, The average duration of chest tube was 47 days in group 1 and 28 days in group 2. The average length of leak treatment was 52 days in group 1 and 35 days in group 2. The average length of postoperative hospital stay was 56 days in group 1 and 39 days in group 2, respectively. 7(35%) patients among 20 patients died from intrathoracic anastomotic leak in group 1; and 3(13%) patients among 23 patients died from intrathoracic anastomotic leak in group 2. Compared with the conventional treatments (group 1), The average duration of chest tube was significantly decreased in the new treatments (group 2) (P < 0.01), as well as the length of leak treatment (P < 0.05) and the length of postoperative hospital stay (P < 0.01). However, there was no significant difference in the mortality rate (P = 0.148 > 0.05).

CONCLUSION

In conclusion, Our results showed this method of the nasogastric placement of sump drainage tube through fistula appears to be an safe, effective, technically feasible treatment option for intrathoracic esophagogastric anastomotic leak. The efficacy and feasibility could be further investigated with a well-designed and large-scale RCT research.

摘要

背景

食管胃吻合口瘘是食管癌手术后最致命的并发症之一。近年来,我们采用了一种新的方法,通过瘘管将胃管置入脓腔,以治疗胸腔内食管胃吻合口瘘。本研究旨在比较新方法与传统治疗方法治疗食管癌术后胸腔内吻合口瘘的疗效。

方法

我院 2008 年 1 月至 2019 年 12 月共行食管切除术和食管胃吻合术 875 例,其中术后发生胸腔内吻合口瘘 43 例(4.9%),纳入本研究并回顾性评估其临床资料。2008 年 1 月至 2012 年 12 月的 20 例(47%)患者接受传统治疗(组 1),即传统的“三管法”,2013 年 1 月至 2019 年 12 月的 23 例(53%)患者接受新治疗(组 2),包括常规治疗和通过瘘管将胃管置入脓腔。

结果

43 例(4.9%)患者经食管造影证实存在胸腔内吻合口瘘。其中,组 1 胸腔引流管留置时间平均为 47 天,组 2 为 28 天。组 1 漏口治疗时间平均为 52 天,组 2 为 35 天。组 1 术后住院时间平均为 56 天,组 2 为 39 天。组 1 20 例患者中有 7 例(35%)死于胸腔内吻合口瘘;组 2 23 例患者中有 3 例(13%)死于胸腔内吻合口瘘。与传统治疗(组 1)相比,新治疗(组 2)胸腔引流管留置时间明显缩短(P<0.01),漏口治疗时间(P<0.05)和术后住院时间(P<0.01)也明显缩短。但死亡率无显著差异(P=0.148>0.05)。

结论

总之,本研究结果表明,经瘘管置入胃管引流的方法似乎是一种安全、有效、技术可行的治疗胸腔内食管胃吻合口瘘的方法。其疗效和可行性可通过设计良好的大规模 RCT 研究进一步探讨。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2bb/7988901/b5304ae3d534/13019_2021_1429_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验